Literature DB >> 26691568

Supplemented vaccination with tandem repeat M2e virus-like particles enhances protection against homologous and heterologous HPAI H5 viruses in chickens.

Byung-Min Song1, Hyun-Mi Kang1, Eun-Kyoung Lee1, Suk Chan Jung1, Min-Chul Kim1, Yu-Na Lee1, Sang-Moo Kang1, Youn-Jeong Lee2.   

Abstract

Highly pathogenic avian influenza (HPAI) H5 viruses derived from A/Goose/Guangdong/1/96 have been continuously circulating globally, severely affecting the public health and poultry industries. The matrix 2 protein ectodomain (M2e) is considered a promising candidate for a universal cross-protective influenza vaccine that provides more effective control over HPAI H5 viruses harboring variant hemagglutinin (HA)-antigens. Here, we evaluated the protective efficacy of a tandem repeat construct of heterologous M2e presented on virus-like particles (M2e5x VLPs) either alone or as a supplement against HPAI H5 viruses in a chicken model. Chickens immunized with M2e5x VLPs alone induced M2e-specific antibodies but were not protected against HPAI H5. The homo- and cross-protective efficacy of M2e5x VLP-supplemented vaccination of chickens was also examined. Importantly, supplementation with M2e5x VLPs induced significantly higher levels of antibodies specific for M2e and different viruses as well as provided improved protection against homologous and heterologous HPAI H5 viruses. Considering the limited efficacy of inactivated vaccines, supplement vaccination with M2e5x VLPs may be an effective measure for preventing outbreaks of HPAI viruses that have the ability to constantly change their antigenic properties in poultry.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chicken; Highly pathogenic avian influenza; M2e5x virus-like particles; Supplemented vaccine

Mesh:

Substances:

Year:  2015        PMID: 26691568      PMCID: PMC4721577          DOI: 10.1016/j.vaccine.2015.11.074

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

Review 1.  Avian influenza vaccines and vaccination in birds.

Authors:  Ilaria Capua; Dennis J Alexander
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

2.  Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea.

Authors:  Jae Min Song; Youn Jeong Lee; Ok Mi Jeong; Hyun Mi Kang; Hye Ryoung Kim; Jun Hun Kwon; Jae Hong Kim; Baik Lin Seong; Yong Joo Kim
Journal:  Vet Microbiol       Date:  2008-02-16       Impact factor: 3.293

3.  Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong.

Authors:  X Xu; N J Cox; Y Guo
Journal:  Virology       Date:  1999-08-15       Impact factor: 3.616

Review 4.  Avian influenza vaccination: the experience in China.

Authors:  H Chen
Journal:  Rev Sci Tech       Date:  2009-04       Impact factor: 1.181

5.  Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.

Authors:  Marina De Filette; Wouter Martens; Anouk Smet; Michael Schotsaert; Ashley Birkett; Patricia Londoño-Arcila; Walter Fiers; Xavier Saelens
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

6.  An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.

Authors:  Marina De Filette; Wouter Martens; Kenny Roose; Tom Deroo; Frederik Vervalle; Mostafa Bentahir; Joel Vandekerckhove; Walter Fiers; Xavier Saelens
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

7.  Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.

Authors:  JingQi Feng; Manxin Zhang; Krystyna Mozdzanowska; Darya Zharikova; Henry Hoff; William Wunner; Robert B Couch; Walter Gerhard
Journal:  Virol J       Date:  2006-12-06       Impact factor: 4.099

8.  Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1.

Authors:  Stephen Mark Tompkins; Zi-Shan Zhao; Chia-Yun Lo; Julia A Misplon; Teresa Liu; Zhiping Ye; Robert J Hogan; Zhengqi Wu; Kimberly A Benton; Terrence M Tumpey; Suzanne L Epstein
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

9.  An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea.

Authors:  Jun Gu Choi; Youn Jeong Lee; Yong Joo Kim; Eun Kyoung Lee; Ok Mi Jeong; Haan Woo Sung; Jae Hong Kim; Jun Hun Kwon
Journal:  J Vet Sci       Date:  2008-03       Impact factor: 1.672

10.  Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine.

Authors:  Benoît Baras; Koert J Stittelaar; James H Simon; Robert J M M Thoolen; Sally P Mossman; Frank H M Pistoor; Geert van Amerongen; Martine A Wettendorff; Emmanuel Hanon; Albert D M E Osterhaus
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

View more
  7 in total

Review 1.  Vaccine approaches conferring cross-protection against influenza viruses.

Authors:  Sai V Vemula; Ekramy E Sayedahmed; Suryaprakash Sambhara; Suresh K Mittal
Journal:  Expert Rev Vaccines       Date:  2017-09-19       Impact factor: 5.217

2.  Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens.

Authors:  Mohamed Elaish; John M Ngunjiri; Ahmed Ali; Ming Xia; Mahmoud Ibrahim; Hyesun Jang; Jagadish Hiremath; Santosh Dhakal; Yosra A Helmy; Xi Jiang; Gourapura J Renukaradhya; Chang-Won Lee
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

3.  Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs.

Authors:  Hae-Ji Kang; Ki-Back Chu; Dong-Hun Lee; Su-Hwa Lee; Bo Ryoung Park; Min-Chul Kim; Sang-Moo Kang; Fu-Shi Quan
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

Review 4.  The Quest for a Truly Universal Influenza Vaccine.

Authors:  Yo Han Jang; Baik Lin Seong
Journal:  Front Cell Infect Microbiol       Date:  2019-10-10       Impact factor: 5.293

5.  Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens.

Authors:  Cynthia Calzas; Molida Mao; Mathilde Turpaud; Quentin Viboud; Joelle Mettier; Thomas Figueroa; Pierre Bessière; Antoine Mangin; Laura Sedano; Pierre-Louis Hervé; Romain Volmer; Mariette F Ducatez; Steve Bourgault; Denis Archambault; Ronan Le Goffic; Christophe Chevalier
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

6.  Supplementation of H7N9 Virus-Like Particle Vaccine With Recombinant Epitope Antigen Confers Full Protection Against Antigenically Divergent H7N9 Virus in Chickens.

Authors:  Dexin Kong; Taoran Chen; Xiaolong Hu; Shaorong Lin; Yinze Gao; Chunmei Ju; Ming Liao; Huiying Fan
Journal:  Front Immunol       Date:  2022-02-21       Impact factor: 7.561

7.  Progress in the development of virus-like particle vaccines against respiratory viruses.

Authors:  Fu-Shi Quan; Swarnendu Basak; Ki-Back Chu; Sung Soo Kim; Sang-Moo Kang
Journal:  Expert Rev Vaccines       Date:  2020-01-18       Impact factor: 5.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.